Learn how the AOD-9604 pill is marketed for fat loss, what research shows, typical dosing, and how it compares with injections and tesamorelin.
The AOD-9604 pill is an oral capsule containing a synthetic fragment of human growth hormone, sold online for fat loss. It is not FDA-approved for human use, and no published human trial has shown that swallowing AOD-9604 produces meaningful fat loss. Almost all of the research on this peptide used injections, not capsules.
What Is Inside an AOD-9604 Pill?
AOD-9604 is a 15-amino-acid piece of human growth hormone, also called hGH 176-191 or the GH fragment. Scientists designed it in the 1990s to keep the fat-metabolizing portion of growth hormone while removing the part linked to growth and blood sugar changes.
Capsule products usually contain 250 mcg to 500 mcg of peptide plus fillers such as rice flour or magnesium stearate. A typical aod 9604 pill form is marketed for belly fat, metabolism, and joint comfort, but those claims come from animal and cell studies rather than trials in people taking the capsule.
The oral format exists mainly because it is easy to sell. Pills ship cheaply, need no needles, and attract buyers who would never inject a research peptide.
Most products carry a 'for research use only' disclaimer. That label lets sellers ship the peptide without proving identity, potency, or safety.
Does Oral AOD-9604 Actually Work?
Peptides break apart easily. Stomach acid and digestive enzymes cut them into fragments before they reach the bloodstream, and oral bioavailability for a peptide of this size is usually tiny. AOD-9604 weighs roughly 1,815 daltons, well above the size that normally crosses the gut wall intact.
The human evidence that exists comes from injections. Early trials of injectable AOD-9604 in adults with obesity showed only modest reductions in fat mass, and the development program was discontinued in the late 2000s. No published trial has tested the oral capsule in people.
Capsule vs. Injectable Powder
Injectable AOD-9604 ships as a lyophilized powder that requires aod 9604 reconstitution with bacteriostatic water before use. Injecting the peptide bypasses digestion, but it does not make the product FDA-approved, legal to sell as a drug, or proven to burn fat. It also adds risks such as contamination and injection-site infections.
Reported Benefits and Side Effects
Sellers promote AOD-9604 for shrinking abdominal fat, improving cholesterol, and supporting cartilage repair. Those claims trace back to rodent and cell research, not to controlled human trials. AOD-9604 is not a cure for obesity, and it is not a replacement for diet, exercise, or prescribed treatment.
User reports most often mention headache, fatigue, nausea, dizziness, and redness at injection sites. The aod 9604 benefits and side effects picture has never been fully mapped in a large human safety study, so long-term risks remain unknown.
Online reviews are weak evidence. Many are written or curated by sellers, buyers cannot verify what is inside a capsule, and weight loss can come from diet, training, or placebo effect.
Common Label Dosing
No established human aod 9604 dosage exists for the oral form. Labels typically suggest 250-500 mcg once daily, a range borrowed from older injectable protocols that were studied for roughly 12 weeks.
Because these capsules are unregulated, the amount of peptide in a pill may not match the label. Independent testing is uncommon, and some products contain little or no detectable peptide at all.
AOD-9604 vs. Tesamorelin and Other Options
Tesamorelin is a growth-hormone-releasing hormone analog approved by the FDA as Egrifta for excess visceral fat in adults with HIV-associated lipodystrophy. It is given as a daily prescription injection and monitored by a physician. The aod 9604 vs tesamorelin comparison therefore comes down to approved, supervised medicine versus an unapproved research peptide.
| Option | Form | Human fat-loss evidence | FDA status |
|---|---|---|---|
| AOD-9604 pill | Oral capsule | None published | Not approved |
| AOD-9604 injection | Subcutaneous injection | Small early trials with modest results | Not approved |
| Tesamorelin (Egrifta) | Subcutaneous injection | Approved for visceral fat in HIV-related lipodystrophy | Approved for that use |
| Tirzepatide (Zepbound) | Weekly injection | Large randomized trials for weight loss | Approved for weight management |
GLP-1 and dual-agonist medications such as semaglutide and tirzepatide have large randomized trials behind them for weight loss. AOD-9604 has none.
Legal Status, Testing, and Safety
- AOD-9604 is not FDA-approved for any human use in the United States.
- The World Anti-Doping Agency bans AOD-9604 as a peptide hormone and growth factor, so athletes can test positive for it.
- Research-use-only peptides are not required to meet pharmacy sterility or purity standards.
- Stacking unapproved peptides with prescription drugs raises the chance of unexpected interactions.
Anyone considering AOD-9604 should speak with a licensed healthcare professional first, especially people who are pregnant, nursing, using insulin, or managing a chronic condition. Proven lifestyle strategies and FDA-approved medications remain the safer route for fat loss.
Frequently Asked Questions
Is the AOD-9604 pill approved by the FDA?
No. AOD-9604 is not FDA-approved for weight loss or any other human use in the United States. Capsules sold online are marketed as research chemicals rather than medicines. Talk with a healthcare professional about FDA-approved options instead.
Does oral AOD-9604 actually work for weight loss?
There is no published human evidence that the oral form works. Peptides of this size are largely broken down during digestion, and the only human trials used injections and reported modest fat changes. Marketing claims about the pill are not supported by controlled studies.
Is AOD-9604 banned in sports?
Yes. The World Anti-Doping Agency lists AOD-9604 as a prohibited peptide hormone and growth factor. Athletes can test positive even if they used the pill form, because anti-doping labs test for the peptide itself.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.